Status:
UNKNOWN
Efficiency and Safety of Different Treatment Strategies in Adults With Pituitary Adenomas With Hypothalamic Involvement
Lead Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions:
Pituitary Adenoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Prospective and randomized evaluate efficiency and safety of different treatment strategies for hypothalamus-invading pituitary adenomas (HIPA)
Detailed Description
There are various treatment strategies for hypothalamus-invading pituitary adenomas (HIPA), such as total resection (TR), subtotal resection with radiosurgery (STR+RS), etc. However,the optimal treatm...
Eligibility Criteria
Inclusion
- Suspected symptomatic or progressively growing pituitary adenoma with Hypothalamic Involvement
- Informed consent
Exclusion
- No follow-up possible
- Emergency surgery without informed consent
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04863456
Start Date
May 1 2021
End Date
December 31 2024
Last Update
April 28 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.